The Efficacy and Safety of Multivitamin and Mineral Supplement Use To Prevent Cancer and Chronic Disease in Adults: A Systematic Review for a National Institutes of Health State-of-the-Science Conference

  1. Han-Yao Huang, PhD, MPH;
  2. Benjamin Caballero, MD, PhD;
  3. Stephanie Chang, MD;
  4. Anthony J. Alberg, PhD, MPH;
  5. Richard D. Semba, MD, MPH;
  6. Christine R. Schneyer, MD;
  7. Renee F. Wilson, MSc;
  8. Ting-Yuan Cheng, MSc;
  9. Jason Vassy, MPH;
  10. Gregory Prokopowicz, MD, MPH;
  11. George J. Barnes II, BA; and
  12. Eric B. Bass, MD, MPH
  1. From the Bloomberg School of Public Health and the School of Medicine, Johns Hopkins University, Baltimore, Maryland.
    1. Figure 1.
      View larger version:
        Figure 1. Relative risk for cancer with use of multivitamin and mineral supplements.

        The lines represent 95% CIs, the midpoints of the lines represent the relative risk estimates, and the size of the boxes represents the relative size of the study sample. SU.VI.MAX = SUpplémentation en VItamines et Minéraux AntioXydants. *Vitamin E + selenium + β-carotene + zinc + vitamin C. † Vitamin E + selenium + β-carotene.

      • Figure 2.
        View larger version:
          Figure 2. Relative risk for all-cause mortality with use of multivitamin and mineral supplements.

          The lines represent 95% CIs, the midpoints of the lines represent the relative risk estimates, and the size of the boxes represents the relative size of the study sample. AREDS = Age-Related Eye Disease Study; SU.VI.MAX = SUpplémentation en VItamines et Minéraux AntioXydants. *Vitamin E + selenium + β-carotene + zinc + vitamin C. † Vitamin E + selenium + β-carotene. ‡ Vitamin E + vitamin C + β-carotene.

        « Previous | Next Article »Table of Contents